男性糖尿病性性功能障碍：多巴胺能药物的作用

Male diabetic sexual impotence: effects of dopaminergic agents.

作者信息

Pierini A A, Nusimovich B

出版信息

Arch Androl. 1981 Jun;6(4):347-50. doi: 10.3109/01485018108987548.

Abstract

A double blind study was carried out with placebo and dopaminergic agents in 100 patients with male diabetic sexual impotence. In basal conditions, mean serum FSH, LH, PRL, and T levels did not significantly differ from those found in a normal control group. No significant variations with the exception of PRL reduction were observed after use of the dopaminergic agents. Sexual activity was improved in 50% of cases after 3-4 dihidroxifenilalanine and 10% of those of the placebo group. In patients with bromocriptine, 20% improved their sexual function without changes in those receiving placebo.

摘要

对100例男性糖尿病性阳痿患者进行了安慰剂和多巴胺能药物的双盲研究。在基础状态下，平均血清促卵泡激素（FSH）、促黄体生成素（LH）、催乳素（PRL）和睾酮（T）水平与正常对照组相比无显著差异。使用多巴胺能药物后，除PRL降低外，未观察到显著变化。服用3 - 4二羟基苯丙氨酸后，50%的患者性功能得到改善，而安慰剂组为10%。服用溴隐亭的患者中，20%性功能改善，而服用安慰剂的患者无变化。